Production & Manufacturing
Production & Manufacturing
Boehringer Ingelheim BioXcellence™ offers reliable world-class biopharmaceuticals contract manufacturing to the pharmaceutical and biotechnology industry.
We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds,...
Articles
The road to digital success in pharma
Pharmaceutical companies are running hard to keep pace with changes brought about by digital technology. Mobile communications, the cloud, advanced analytics, and the Internet of Things are among the innovations that are starting to transform the healthcare industry in...
Production & Manufacturing
Galena Biopharma Acquires Mills Pharmaceuticals
Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented,...
Production & Manufacturing
Bayer HealthCare launches oncology treatment Xofigo in UK
Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. The launch follows a positive...
Production & Manufacturing
PharmaCell signs deal to produce Dendreon’ Provenge in Europe
Netherlands-based PharmaCell has entered into an agreement with Dendreon to be the contract manufacturing organization (CMO) for the European commercial production of its recently approved cellular immunotherapy product Provenge dispersion for infusion. Provenge is an...
Production & Manufacturing
Aspen proposes to acquire GSK’s thrombosis brands and NDB site
Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has received a proposal from Aspen Global and Aspen Pharmacare Holdings for its thrombosis brands and Notre-Dame de Bondeville (NDB) site. The offer includes the transfer of GSK's...
Production & Manufacturing
Medicago wins European patent for influenza virus-like particles in plants
The European Patent Office (EPO) has granted Medicago a patent protecting exclusive rights to produce influenza virus-like particles (VLPs) in plants through July 2028. Patent titled 'Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
